Osaic Holdings
HRMY icon

Osaic Holdings’s Harmony Biosciences HRMY Stock Holding History

Osaic Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
6,798
-56
-0.8% -$1.77K ﹤0.01% 4251
2026
Q1 		$192K Buy
6,854
+5,110
+293% +$168K ﹤0.01% 4178
2025
Q4 		$65.3K Buy
1,744
+556
+47% +$18.3K ﹤0.01% 5051
2025
Q3 		$42.1K Buy
1,188
+19
+2% +$655 ﹤0.01% 5424
2025
Q2 		$36.9K Buy
1,169
+79
+7% +$2.54K ﹤0.01% 5255
2025
Q1 		$36.2K Buy
1,090
+134
+14% +$4.8K ﹤0.01% 4944
2024
Q4 		$32.9K Buy
956
+49
+5% +$1.68K ﹤0.01% 5000
2024
Q3 		$36.3K Buy
907
+672
+286% +$23.6K ﹤0.01% 4965
2024
Q2 		$7.09K Buy
+235
New +$7.07K ﹤0.01% 6000
2024
Q1 		– Sell
-492
Closed -$15.9K – 7288
2023
Q4 		$15.9K Sell
492
-2,683
-85% -$74.9K ﹤0.01% 5607
2023
Q3 		$104K Buy
3,175
+1,452
+84% +$50.4K ﹤0.01% 4485
2023
Q2 		$60.6K Sell
1,723
-621
-26% -$21.4K ﹤0.01% 4806
2023
Q1 		$76.5K Sell
2,344
-9,071
-79% -$413K ﹤0.01% 4665
2022
Q4 		$628K Buy
11,415
+6,458
+130% +$355K ﹤0.01% 2818
2022
Q3 		$219K Sell
4,957
-13,138
-73% -$641K ﹤0.01% 3654
2022
Q2 		$882K Sell
18,095
-1,567
-8% -$70.5K ﹤0.01% 2403
2022
Q1 		$957K Buy
19,662
+19,047
+3,097% +$777K ﹤0.01% 2617
2021
Q4 		$28K Buy
615
+479
+352% +$19.1K ﹤0.01% 5556
2021
Q3 		$5K Buy
+136
New +$4.38K ﹤0.01% 6530
2021
Q1 		– Sell
-250
Closed -$9K – 6867
2020
Q4 		$9K Hold
250
– – ﹤0.01% 5565
2020
Q3 		$8K Buy
+250
New +$9.12K ﹤0.01% 5379

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's HRMY Position: Q2 2026 in Review

Osaic Holdings reduced its Harmony Biosciences (HRMY) stake by 0.82% in Q2 2026, selling an estimated $1.77K and leaving 6,798 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #4251.

Osaic Holdings first reported a position in HRMY in Q3 2020 and has held it in 21 quarters since. The position peaked at $957K in Q1 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Osaic Holdings held 6,798 shares of Harmony Biosciences worth $248K as of Q2 2026.
  • Osaic Holdings sold 56 Harmony Biosciences shares in Q2 2026, an estimated $1.77K.
  • Harmony Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4251 holding.
  • Osaic Holdings first reported a position in Harmony Biosciences in Q3 2020 and has held it in 21 quarters since.
  • Osaic Holdings's Harmony Biosciences position peaked at $957K in Q1 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.